Table 1

Baseline patient characteristics

Characteristic Oral flecainide (n=40)iv flecainide (n=39)p Value
Mean (SD) age (years)64.1 (14.5)64.5 (15.3)0.89
Sex (M/F)22/1824/150.55
Duration of AF (h) (mean (range))10.8 (1–40)11.0 (1–36)0.91
History of ischaemic heart disease8/4011/390.40
History of hypertension14/4010/390.38
  • AF, atrial fibrillation; iv, intravenous.